the Street won't take an interest in a security with an imminent RS - they'll wait it out - and if there is a catalyst to propell the shareprice north, it will be dicey at best to expect the stick & stay crowd to remain after the run up
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links